| Filed On | Filing |
|---|---|
| 06 Jul 2026 |
Form 3: Ewon Comfortech Co., Ltd., 10% owner
Holds 5,500,000 shares of Common Stock, par value $0.0001 per share |
| 15 Aug 2025 |
Form 3: Iris Acquisition Holdings Llc, 10% owner
Holds 6,900,000 shares of Common Stock |
| 23 Jul 2025 |
Form 3: Lemons Ii Philip Wayne, Director
No securities owned |
| 21 Jul 2025 |
Form 3: Baek Richard JaiHwan, Director
No securities owned |
| 27 Jun 2025 |
Form 3: Kh Feelux Co., Ltd, 10% owner
Holds 4,000,000 shares of Common Stock |
| 16 Jun 2025 |
Form 3: Valetudo Therapeutics Llc, 10% owner and 1 other
Holds 6,169,406 shares of Common Stock, par value $0.0001 per share |
| 01 May 2025 |
Form 3: Lee Eun Sook, Director
No securities owned |
| 30 Apr 2025 |
Form 3: Baek Ji Yeon, Director
No securities owned |
| 30 Apr 2025 |
Form 3: Kim Chris, Director
Holds 6,169,406 shares of Common Stock, par value $0.0001 per share |
| 30 Apr 2025 |
Form 3: Choi Beom Kyu, Chief Technology Officer
No securities owned |
| 30 Apr 2025 |
Form 3: Yoo Byong Chul, Chief Science Officer
No securities owned |
| 30 Apr 2025 |
Form 3: Lee Sang-Jin, Head of Research & Development
No securities owned |
| 30 Apr 2025 |
Form 3: Fernandez Nicholas, Director
No securities owned |
| 30 Apr 2025 |
Form 3: Dam Scott, Chief Financial Officer
No securities owned |
Loading...
